> The assumption by regulators that the mRNA products would behave similarly to more traditional vaccine products merely by virtue of having the label of “vaccine” applied to them - thereby permitting substantial tranches of pre-clinical research to be skipped - was deeply flawed. It has resulted in billions having been injected with multiple doses of a product about which there are an unacceptable number of significant unknowns. I would call it less of an assumption and more of a forced lie.